graphad prism version 6.0 (SPSS Inc)
90
Structured Review
SPSS Inc
graphad prism version 6.0
Graphad Prism Version 6.0, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graphad+prism+version+6%2E0/graphad+prism+version+6+0/pm24623035-75-5-10
Average 90 stars, based on 1 article reviews
Graphad Prism Version 6.0, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graphad+prism+version+6%2E0/graphad+prism+version+6+0/pm24623035-75-5-10
Average 90 stars, based on 1 article reviews
graphad prism version 6.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy. Article Snippet: Background and Purpose.. This study was aimed at using proximity ligation assay (PLA) followed by enzyme-linked immunosorbent assay (ELISA) to identify serum biomarkers that predict treatment response and survival for patients with esophageal squamous cell carcinoma (ESCC) undergoing neoadjuvant concurrent chemoradiotherapy (CCRT) followed by esophagectomy.. Methods. |